Literature DB >> 6230454

Indomethacin sensitive suppressor cells in Crohn's disease: a possible role in decreased lymphocyte responsiveness.

R M Victorino.   

Abstract

Peripheral blood mononuclear cells from 18 patients with Crohn's disease were assayed for the activity of indomethacin-sensitive suppressor monocytes. This activity was found to be significantly increased when compared with 16 healthy controls. Patients were also found to have decreased lymphocyte responses to PHA and this impairment correlated with the increased suppression. In contrast, the short-lived suppressor cell activity analyzed simultaneously was found to be decreased as reported in previous studies. Thus, distinct suppressor systems may be differently affected in Crohn's disease and such immunoregulatory aberrations may explain some of the immunological alterations previously reported in Crohn's disease.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6230454

Source DB:  PubMed          Journal:  J Clin Lab Immunol        ISSN: 0141-2760


  4 in total

1.  Evidence for prostaglandin-producing supressor cells in HCV patients with normal ALT.

Authors:  Rui Marinho; Ruth Pinto; Maria Livia Santos; MouraMiguelCarneiro de
Journal:  Dig Dis Sci       Date:  2002-03       Impact factor: 3.199

2.  Depressed T cell reactivity to recall antigens in Crohn's disease before and after surgical resection.

Authors:  G D'Haens; M Hiele; P Rutgeerts; K Geboes; J L Ceuppens
Journal:  Gut       Date:  1994-12       Impact factor: 23.059

3.  Diagnostic value of specific T cell reactivity to drugs in 95 cases of drug induced liver injury.

Authors:  V A Maria; R M Victorino
Journal:  Gut       Date:  1997-10       Impact factor: 23.059

4.  Evidence for prostaglandin-producing suppressor cells in drug-induced liver injury and implications in the diagnosis of drug sensitization.

Authors:  R M Victorino; V A Maria; L A Pinto
Journal:  Clin Exp Immunol       Date:  1992-01       Impact factor: 4.330

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.